Literature DB >> 11498507

The cholecystokinin analogues JMV-180 and CCK-8 stimulate phospholipase C through the same binding site of CCK(A) receptor in rat pancreatic acini.

E Sarri1, B Ramos, G M Salido, E Claro.   

Abstract

1. This study was designed to address the controversy related to the involvement of phospholipase C in the signalling pathway linked to CCK(A) receptor stimulation by the cholecystokinin analogue JMV-180, a full agonist for amylase release, in rat pancreatic acini. 2. JMV-180 was shown to stimulate phospholipase C by measuring the incorporation of [(32)P]-orthophosphoric acid ([(32)P]-Pi) into phosphatidic acid (PtdOH) and phosphatidylinositol (PtdIns). Both responses elicited by JMV-180 were time and concentration dependent. Maximal effects elicited by JMV-180 were 39.08+/-0.72 and 8.02+/-0.40% for the labelling of [(32)P]-PtdIns and [(32)P]-PtdOH, respectively, as compared to the maximal effects of CCK-8, a full agonist of the CCK(A) receptor. 3. [(32)P]-Pi incorporation into PtdOH and PtdIns was sensitive to lithium, demonstrating that both responses are a consequence of phospholipase C activation. However, since lithium blocks the phosphoinositide cycle by an uncompetitive mechanism, its effect was only apparent at high concentrations of CCK-8 (>10 pM), which elicited stimuli above 20 and 60% of the maximal [(32)P]-PtdOH and [(32)P]-PtdIns labelling, respectively. 4. JMV-180 inhibited the incorporation of [(32)P]-Pi into PtdOH and PtdIns as stimulated by CCK-8, down to its own maximal effect. The estimated IC(50) values for the inhibition curves were not significantly different from those calculated assuming the same single binding site for both agonists. These results indicated that the well established role of JMV-180 as a partial agonist for CCK(A) receptor-linked signalling responses, also applies for the stimulation of phospholipase C. 5. The comparison of CCK-8 and JMV-180 dose-response curves of amylase release to those of PtdIns and PtdOH labelling with [(32)P]-Pi showed the existence of an amplification mechanism between phospholipase C and amylase release for both agonists. 6. In conclusion, we show that JMV-180, as well as CCK-8, stimulate phospholipase C upon interaction with the same binding site at the CCK(A) receptor in rat pancreatic acini.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11498507      PMCID: PMC1621142          DOI: 10.1038/sj.bjp.0704190

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  30 in total

Review 1.  Inositol phospholipids and cell surface receptor function.

Authors:  R H Michell
Journal:  Biochim Biophys Acta       Date:  1975-03-25

2.  CCK, carbachol, and bombesin activate distinct PLC-beta isoenzymes via Gq/11 in rat pancreatic acinar membranes.

Authors:  A Piiper; D Stryjek-Kaminska; R Klengel; S Zeuzem
Journal:  Am J Physiol       Date:  1997-01

Review 3.  Phospholipase D: enzymology, mechanisms of regulation, and function.

Authors:  J H Exton
Journal:  Physiol Rev       Date:  1997-04       Impact factor: 37.312

4.  Cholecystokinin octapeptide CCK-8 and carbachol reduce [(32)P]orthophosphate labeling of phosphatidylcholine without modifying phospholipase D activity in rat pancreatic acini.

Authors:  E Sarri; B Ramos; G Salido; E Claro
Journal:  FEBS Lett       Date:  2000-12-01       Impact factor: 4.124

5.  Kinetics of amylase release by dispersed acini prepared from guinea pig pancreas.

Authors:  S R Peikin; A J Rottman; S Batzri; J D Gardner
Journal:  Am J Physiol       Date:  1978-12

6.  Cholecystokinin-JMV-180 and pilocarpine are potent inhibitors of cholecystokinin and carbachol actions on guinea pig pancreatic acinar cells.

Authors:  L Sjödin; E Viitanen; E Gylfe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1997-05       Impact factor: 3.000

7.  Two functionally distinct cholecystokinin receptors show different modes of action on Ca2+ mobilization and phospholipid hydrolysis in isolated rat pancreatic acini. Studies using a new cholecystokinin analog, JMV-180.

Authors:  T Matozaki; B Göke; Y Tsunoda; M Rodriguez; J Martinez; J A Williams
Journal:  J Biol Chem       Date:  1990-04-15       Impact factor: 5.157

8.  A cloned CCK-A receptor transduces multiple signals in response to full and partial agonists.

Authors:  D I Yule; M J Tseng; J A Williams; C D Logdson
Journal:  Am J Physiol       Date:  1993-11

9.  Calcium release by cholecystokinin analogue OPE is IP3 dependent in single rat pancreatic acinar cells.

Authors:  H Y Gaisano; D Wong; L Sheu; J K Foskett
Journal:  Am J Physiol       Date:  1994-07

10.  Phosphorylation of cholecystokinin receptors expressed on Chinese hamster ovary cells. Similarities and differences relative to native pancreatic acinar cell receptors.

Authors:  F Ozcelebi; R V Rao; E Holicky; B J Madden; D J McCormick; L J Miller
Journal:  J Biol Chem       Date:  1996-02-16       Impact factor: 5.157

View more
  2 in total

1.  TMEM16B determines cholecystokinin sensitivity of intestinal vagal afferents of nodose neurons.

Authors:  Runping Wang; Yongjun Lu; Michael Z Cicha; Madhu V Singh; Christopher J Benson; Christopher J Madden; Mark W Chapleau; François M Abboud
Journal:  JCI Insight       Date:  2019-03-07

2.  Comparative pharmacology of cholecystokinin induced activation of cultured vagal afferent neurons from rats and mice.

Authors:  Dallas C Kinch; James H Peters; Steven M Simasko
Journal:  PLoS One       Date:  2012-04-13       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.